Fatigue presentation, severity, and related outcomes in a prospective cohort following post-COVID-19 hospitalization in British Columbia, Canada. — CFSMEATLAS
Fatigue presentation, severity, and related outcomes in a prospective cohort following post-COVID-19 hospitalization in British Columbia, Canada.
Magel, Tianna, Meagher, Emily, Boulter, Travis et al. · Frontiers in medicine · 2023 · DOI
Quick Summary
This study followed 88 people who were hospitalized with COVID-19 to see how many experienced long-lasting fatigue afterward. Two-thirds of patients had fatigue at 3 months, though this improved somewhat by 6 months, with about 60% still experiencing it. People who had more existing health conditions before COVID-19 were more likely to develop fatigue, suggesting that previous health status may influence recovery.
Why It Matters
This study provides important data on the prevalence and persistence of post-viral fatigue after COVID-19 hospitalization, helping clarify the overlap between post-COVID fatigue and ME/CFS. Understanding which patient factors predict longer-lasting fatigue can help identify those at higher risk and inform clinical management strategies.
Observed Findings
67% of patients experienced fatigue at 3 months post-COVID hospitalization, declining to 60% at 6 months
16% experienced substantial fatigue at 3 months, declining to 6% at 6 months
Pre-existing comorbidities were significantly associated with both fatigue and substantial fatigue at 3-month follow-up
Shortness of breath, self-care ability, and follow-up duration were all associated with fatigue outcomes at 3 months
A meaningful proportion (approximately 60%) continued to have fatigue at 6-month follow-up despite initial improvement
Inferred Conclusions
Post-viral fatigue is common after COVID-19 hospitalization but tends to improve over the first 6 months
Pre-existing comorbidities are a significant independent predictor of post-COVID fatigue development and severity
Further research is needed to determine whether post-COVID fatigue represents true ME/CFS or a related but distinct condition
Clinicians should particularly monitor patients with multiple comorbidities for prolonged fatigue after COVID-19
Remaining Questions
What are the biological mechanisms underlying post-COVID fatigue, and how do they relate to ME/CFS pathophysiology?
What This Study Does Not Prove
This study does not prove that COVID-19 directly causes ME/CFS, only that post-viral fatigue symptoms are common and may meet some clinical features. It cannot establish causality or definitively determine whether post-COVID fatigue is mechanistically identical to ME/CFS, as diagnostic criteria assessment is not fully described. The specialized clinical setting may limit generalizability to all hospitalized COVID-19 patients.
Tags
Symptom:Fatigue
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleMixed Cohort